Insulin-rationing Common among People with Diabetes Under 65
A study concluded by Michael Fang, PhD, MHS and Elizabeth Selvin, PhD, MPH revealed that adults with diabetes younger than 65 were more likely to ration insulin use due to out of pocket costs. While President Biden signed the Inflation Reduction Act, 71% of all adults rationing for insulin were not eligible for this new policy, hence their continued vulnerability to rationing. Fortunately, Eli Lily, Sanofi, and Novo Nordisk have all decided to cap insulin prices at $35 a month, which would improve insulin affordability for people who aren’t covered by the Inflation Reduction Act. Regardless, paying $35 a month for insulin is still not ideal, especially with the necessary dependence on insulin. There needs to be more reform for more accessibility to insulin.
Click here for more information.